I'm not aware of any I/O company (non checkpoint inhibitors) that's currently ahead of Advaxis chronologically for cervical, H&N, PSA cancers. But, I'm not an expert in the area, and I don't pretend to be one on TV or on a message board. I'm just a @wmtgreeter with a subpar sub-education. It does not mean there are not companies that do run clinical trials on those above indications that are Ph2 or Ph3.
News 
Market Data 
Discover 
AI
